Peritoneal Dialysis Market - Global Forecast 2025-2032

The peritoneal dialysis market is undergoing transformative change, driven by rising chronic kidney disease incidence, evolving care models, and rapid technological progress that delivers greater patient autonomy and operational efficiency for healthcare providers. Senior decision-makers now face a landscape where the quality, accessibility, and economics of peritoneal dialysis are interconnected with broader renal care trends.

Market Snapshot: Strong Growth and Expanding Renal Care Options

The global peritoneal dialysis market grew from USD 9.86 billion in 2024 to USD 10.43 billion in 2025. With a CAGR of 6.09%, the market is projected to reach USD 15.83 billion by 2032. This growth trajectory reflects increased adoption of home-based renal therapies and stakeholder efforts to expand access. Both patient and provider communities are drawn to peritoneal dialysis as an efficient, patient-centric alternative, supported by health system reforms and advances in device safety and user experience.

Scope & Segmentation: Diverse Offerings and Global Reach

• Product Types: Accessories (peritoneal dialysis solution bags, drainage bags, catheter kits, transfer sets), PD machines (automated cyclers, continuous ambulatory devices), and peritoneal solutions (biocompatible, glucose-based, low-glucose blends).
• Therapeutic Areas: Acute kidney injury, chronic kidney disease, congestive heart failure.
• Applications: Diabetic nephropathy, glomerulonephritis, lupus nephritis, polycystic kidney disease.
• End Users: Dialysis centers, home healthcare models, and hospitals.
• Regional Coverage: Americas (including North America—United States, Canada, Mexico—and Latin America—Brazil, Argentina, Chile, Colombia, Peru); Europe, Middle East & Africa (spanning key countries across western and eastern Europe, Middle East, and Africa); Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, and Taiwan).
• Companies Analyzed: Leading names include Advin Health Care, Angiplast Pvt. Ltd., B. Braun Medical Ltd, Baxter International, Becton, Dickinson and Company, Fresenius Medical Care AG, Diaverum AB by M42, and many others across the supply, device, and solution value chains.

Key Takeaways for Stakeholders

• Advancements in automated systems and remote monitoring tools are reshaping peritoneal dialysis by supporting real-time therapy adjustments and reducing staff burden.
• Patient training and simulation modules have been strengthened, resulting in higher adherence and fewer hospitalization events in home settings.
• Strategic investments in local manufacturing and smarter supply logistics are making peritoneal dialysis more resilient to external disruptions, including regulatory shifts.
• Growth in the Asia-Pacific region is propelled by expanding training programs and incentives for domestic device manufacturing.
• Differentiated product portfolios, including biocompatible solutions and digitally enabled consumables, are becoming standard competitive levers among top market participants.

Tariff Impact: Navigating US Tariff Adjustments and Supply Chain Realignment

Forthcoming US tariff adjustments on imported dialysis equipment are prompting stakeholders to modify sourcing strategies by seeking alternative manufacturing locations and reinforcing domestic supplier partnerships. This shifting cost landscape encourages innovation through modular system design, localized production, and integration of value-based contracting, helping providers maintain affordability and uninterrupted product availability even as external economic pressures evolve.

Methodology & Data Sources

The report uses a robust, multi-tiered research approach, including structured interviews with nephrologists and industry experts, secondary analysis of peer-reviewed publications, regulatory filings, and triangulation with financial disclosures. This methodology ensures that findings reflect real-world practice and market conditions, offering senior leaders actionable intelligence built on validated, credible data.

Why This Report Matters

• Delivers a strategic decision framework for evaluating partnerships, procurement, and expansion opportunities across international markets in peritoneal dialysis.
• Identifies emerging risks and value drivers relevant to senior leadership, from supply chain agility and cost adaptation to patient outcomes and regulatory compliance.

Conclusion

The peritoneal dialysis market is poised for continued evolution, with stakeholder innovation and adaptive strategies vital for sustained competitive advantage. Senior decision-makers equipped with these insights can navigate dynamic renal care trends and capitalize on future opportunities.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.